Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
167.00    2.00 (1.21%)
Bid:
165.50
Ask:
168.50
Spread: 3.00 (1.813%)
Market Cap: £32.61m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

Palace Capital's sales programme continues

22 Jan 2018 07:00

RNS Number : 4626C
Palace Capital PLC
22 January 2018
 

Palace Capital PLC

 

("Palace Capital" or the "Company")

 

Palace Capital's sales programme continues

 

Palace Capital, the property investment company that focuses on commercial property outside London, today announces that it has sold 138 Molesey Avenue, West Molesey, Surrey for £595,000 to a private investor.

 

This industrial building comprises 5,536 sq ft and was acquired by Palace Capital as part of the £32 million PIH Portfolio in August 2014. It is let until June 2021 at a rental of £40,000 per annum exclusive. The sale price was at a premium of 10% to book value as at 30 September 2017.

 

In addition, the Company has now completed the sale of the former Polestar building at Marsh Barton Exeter for £3.29m to Travis Perkins. This sale was announced in the Company's interim results on 4 December 2017 and also achieved a 10% premium to book value as at 30 September 2017.

 

Neil Sinclair, Chief Executive of Palace Capital, commented: "Although not a large sale in terms of our overall portfolio, the disposal of the West Molesey property further demonstrates our strategy of disposing of small properties or those where little value added can be achieved. This is part of our agreed strategy to actively manage our asset base, constantly seeking to retain and invest in better performing properties. We are also pleased to have completed the disposal of the Polestar building in Exeter as this had presented a number of management challenges since we acquired it as part of the Quintain portfolio in 2013."

 

Date: 22 January 2018

 

For further information, contact:

 

Palace Capital plc

Neil Sinclair, Chief Executive

Stephen Silvester, Finance Director

Tel. +44 (0)20 3301 8331

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Nick Naylor / James Reeve / Asha Chotai

Tel. +44 (0)20 3328 5656

 

Arden Partners plc (Joint Broker)

Chris Hardie / Ciaran Walsh

Tel. +44 (0)207 614 5917

 

Capital Access Group (Financial PR)

Scott Fulton

Tel. +44 (0)20 3763 3400

 

About Palace Capital plc (www.palacecapitalplc.com):

 

Palace Capital is a UK property investment company admitted to trading on the AIM Market of the London Stock Exchange (LSE: PCA). The Company is not sector specific and looks for opportunities where it can enhance the long-term income and capital value through asset management and strategic capital development in locations outside London. In its last reported financial year, Palace Capital produced a 20.0% increase in adjusted profit before tax, a 7.0% uplift in EPRA NAV per share and a 16.0% increase in dividends.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISBBMMTMBATTJP
Date   Source Headline
2nd Aug 20247:00 amRNSDirector/PDMR Shareholding
24th Jul 202411:03 amRNSResult of AGM
24th Jul 202410:53 amRNSHolding(s) in Company
24th Jul 20247:00 amRNSDISPOSALS AND CASH UPDATE
22nd Jul 20248:55 amRNSHolding(s) in Company
18th Jul 20247:00 amRNSDirector/PDMR Shareholding
17th Jul 20242:30 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSTransaction in Own Shares
11th Jul 20247:00 amRNSResult of Tender Offer
9th Jul 202410:45 amRNSResult of General Meeting
19th Jun 20247:00 amRNSAnnual Report and Notice of Annual General Meeting
13th Jun 20247:00 amRNSTender Offer
6th Jun 20247:00 amRNSPreliminary Results for year ended 31 March 2024
4th Jun 20247:00 amRNSNotice of Results
29th Apr 20241:15 pmRNSBoulton House disposal
18th Apr 20247:00 amRNSDISPOSALS AND DEBT UPDATE
28th Mar 202412:45 pmRNSTotal Voting Rights
12th Mar 20247:00 amRNSDividend Declaration
8th Feb 20243:49 pmRNSHolding(s) in Company - Amendment
8th Feb 20243:30 pmRNSHolding(s) in Company
8th Feb 20243:29 pmRNSHolding(s) in Company
7th Feb 20247:00 amRNSDISPOSALS AND DEBT UPDATE
4th Dec 20234:00 pmRNSResult of General Meeting
15th Nov 20233:15 pmRNSHolding(s) in Company
15th Nov 20237:02 amRNSNotice of General Meeting
15th Nov 20237:01 amRNSDirectorate Change
15th Nov 20237:00 amRNSInterim Results
17th Oct 20234:00 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSDividend Declaration
6th Sep 20237:00 amRNSTransaction in Own Shares
4th Sep 20231:40 pmRNSDirector Declaration
29th Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
21st Aug 20237:00 amRNSDirector Dealing
15th Aug 202310:07 amRNSNotification of Major Holdings
15th Aug 20239:56 amRNSNotification of Major Holdings
14th Aug 20237:00 amRNSTransaction in Own Shares
10th Aug 20237:00 amRNSTransaction in Own Shares
8th Aug 20237:00 amRNSShare Buyback and Total Voting Rights
2nd Aug 20237:00 amRNSSale of Maidenhead office property for £9.6m
26th Jul 20232:15 pmRNSResult of AGM
26th Jul 20237:00 amRNSAGM Trading Update
19th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20237:00 amRNSShare Buyback and Total Voting Rights
30th Jun 20237:00 amRNSTransaction in Own Shares
28th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSAnnual Report and Notice of Annual General Meeting
23rd Jun 20237:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.